Urology
Volume 68, Issue 2, Supplement , Pages 9-16, August 2006

Development and validation of patient-reported outcomes measures for overactive bladder: A review of concepts

  • Karin S. Coyne

      Affiliations

    • Center for Health Outcomes Research, United BioSource Corporation, Bethesda, Maryland, USA
    • Corresponding Author InformationReprint requests: Karin S. Coyne, PhD, MPH, United BioSource Corporation, 7101 Wisconsin Avenue, Suite 600, Bethesda, Maryland 20814.
    • Karin S. Coyne is a consultant to Pfizer Inc.
    • ,
  • Andrea Tubaro

      Affiliations

    • Sant’Andrea Hospital, “La Sapienza” University, Rome, Italy
    • ,
  • Linda Brubaker

      Affiliations

    • Departments of Obstetrics, Gynecology, and Urology, Loyola University Medical Center, Maywood, Illinois, USA
    • Linda Brubaker receives research funding from Q-Med, Pfizer Inc, and Allergan and receives consultant/speaker honoraria from Q-Med, Novartis, Pfizer Inc, and Astellas.
    • ,
  • Tamara Bavendam

      Affiliations

    • Pfizer Inc, New York, New York, USA
    • Tamara Bavendam is an employee of Pfizer Inc.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0090-4295(06)00770-9

doi:10.1016/j.urology.2006.05.042

Urology
Volume 68, Issue 2, Supplement , Pages 9-16, August 2006

Article Tools